Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07419243Phase 2Recruiting
Phase 2, open-label trial in Cow's milk allergy (CMA) and Hen's Egg Allergy (2 arms), sponsored by Fundación de Investigación Biomédica del Hospital Universitario de La Princesa. Primary endpoint: Proportion of patients achieving Sustained Unresponsiveness (SU) vs natural resolution at 24 months. Started Feb 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07419243.